Peer-influenced content. Sources you trust. No registration required. This is HCN.

Annals of Internal MedicineHydroxychloroquine Dose and Risk for Incident Retinopathy

Among more than 3,000 patients taking hydroxychloroquine, overall cumulative incidence for developing retinopathy were 2.5% and 8.6% at 10 and 15 years respectively. Incidence was strongly dose-related and most cases were mild.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form